Logo
x

Search

Subscribe Now

EU Approval

Insights+: EMA Marketing Authorization of New Drugs in April 2024

Insights+: EMA Marketing Authorization of New Drugs in April 2024

  • May 21, 2024
Insights+: EMA Marketing Authorization of New Drugs in March 2024

Insights+: EMA Marketing Authorization of New Drugs in March 2024

  • April 22, 2024
Insights+: EMA Marketing Authorization of New Drugs in February 2024

Insights+: EMA Marketing Authorization of New Drugs in February 2024

  • March 20, 2024
Insights+: EMA Marketing Authorization of New Drugs in January 2024

Insights+: EMA Marketing Authorization of New Drugs in January 2024

  • February 21, 2024
UCB's Vimpat (lacosamide) Receives CHMP's Positive Opinion for Primary Generalized Tonic-Clonic Seizures

UCB's Vimpat (lacosamide) Receives CHMP's Positive Opinion for Primary Generalized Tonic-Clonic Seizures

  • October 23, 2020
Novartis Receives EU Approval for Gene Therapy Luxturna (voretigene neparvovec) in Patients with Rare Inherited Retinal Disease

Novartis Receives EU Approval for Gene Therapy Luxturna (voretigene neparvovec) in Patients with Rare Inherited Retinal Disease

  • November 26, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.